Loading quotes...

Forecast

The analysts' average price target is €1.59 (+45.87%). The median is €1.59 (+45.87%).

Buy
  5
Hold
  1
Sell
  1

Discussions in the community

There is no discussion about this asset yet.

Start discussion

  • Aemetis reports Q2 revenue up 20% as RNG and ethanol projects drive results

    Aemetis posted Q2 2026 revenue of $62.7 million, up 20% year‑over‑year, with operating income improving to $5.8 million and net loss narrowing to $9.4 million; adjusted EBITDA rose to $9.7 million. Section 45Z production tax credits contributed $8.6 million and recent California LCFS pathway approvals materially increase the value of dairy RNG sales. Management highlighted near‑term milestones including two additional dairy digesters, completion of an MVR energy‑efficiency project at the Keyes ethanol plant expected to boost annual cash flow by about $32 million, doubled corn oil recovery capacity, and India biodiesel allocations expected to generate roughly $17 million in revenue. » More on finance.yahoo.com


  • Aemetis cuts loss in Q2 2026 but misses revenue forecast

    Aemetis reported Q2 2026 revenue growth of 20% to $62.7 million, but came in about 10.3% below analysts’ expectations. Adjusted loss per share improved to a loss of $0.13 (expected -$0.26) and adjusted EBITDA turned positive at $9.7 million; operating income rose to $5.8 million. The company highlighted liquidity gains from Section 45Z tax credits, but cites only $1 million in cash, high debt and dependence on regulatory credits as risks; the MVR project and LCFS/India businesses are expected to strengthen future cash flows. » More on de.investing.com


  • Aemetis reports biodiesel supply contract for India worth about $17 million

    Aemetis shares rose after its subsidiary Universal Biofuels secured supply contracts worth about $17 million. Universal Biofuels is to deliver more than 18 million liters of biodiesel within three months to three state oil marketing companies in India, supporting the national biofuel strategy. The unit operates a plant in Kakinada with an annual capacity of around 80 million gallons and uses a proprietary enzymatic process; additional supply orders are expected before the end of 2026. Universal Biofuels is evaluating expansion opportunities in India, including biogas from dairy waste, ethanol, a sustainable aviation fuel project and a possible IPO. » More on de.investing.com


  • Aemetis disappoints with Q1 results, shares fall about 20%

    Aemetis reported Q1 2026 EPS of -$0.33 and revenue of $54.6 million, missing both EPS and revenue estimates by a wide margin. Despite year-over-year revenue growth of 27% and improvements in gross profit and operating loss, adjusted EBITDA remained negative at -$1.3 million and the net loss was $21.7 million. The shares plunged about 20% after the announcement but showed slight recovery in premarket trading. Management emphasizes a focus on renewable fuels projects but sees ongoing execution and profitability risks. » More on de.investing.com


  • Aemetis misses Q1 2026 forecasts, stock down in premarket

    Aemetis reported Q1 2026 earnings per share of -$0.33 (expectation -$0.28) and revenue of $54.6 million versus forecasted $69.4 million. Revenue rose 27% year‑on‑year and gross profit improved to $2.8 million (prior year gross loss $5.1 million), but the missed numbers sent the stock down 4.6% in premarket trading. The company still expects quarterly losses, but sees improvements by fiscal 2027 and is counting on expanding RNG projects and securing new LCFS certifications to boost profitability. » More on de.investing.com

Financials

In the last quarter, Aemetis had revenue of €77.83m and net profit of €4.6m
(EUR) September 2026
YoY
Revenue 77.83m 54.30%
Gross profit 26.02m 52,747.48%
Net profit 4.6m 122.73%
EBITDA 20.69m 478.16%

Fundamentals

Metric Value
Market capitalization
€79.62m
Number of shares
73.1m
52-week high/low
€3.45 - €1.01
Dividends No
Beta
1.47
P/E ratio
-2.55
PEG ratio
-0.02
P/B ratio
0.00
P/S ratio
0.34

Company profile

Aemetis, Inc. operates as a renewable natural gas and renewable fuels company in North America and India. It operates through three segments: California Ethanol, Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the acquisition, development, and commercialization of negative carbon intensity products and technologies that replace traditional petroleum-based products. It sells biodiesel primarily to government oil marketing companies, transport companies, resellers, distributors, and private refiners through its own sales force and independent sales agents, as well as to brokers who resell the product to end-users. The company also produces and sells ethanol; and wet distillers grains, distillers corn oil, and condensed distillers solubles to dairies and feedlots as animal feed. In addition, it produces dairy biogas; produces and sells high-grade alcohol and various feed products, as well as hand sanitizers; and researches and develops conversion technologies using waste feedstocks to produce biofuels and biochemicals. The company was formerly known as AE Biofuels, Inc. and changed its name to Aemetis, Inc. in November 2011. Aemetis, Inc. was founded in 2005 and is headquartered in Cupertino, California.

Name
Aemetis
CEO
Eric A. McAfee
Headquarters Cupertino, ca
USA
Website
Sector
Energy
Industry
Oil, Gas & Consumable Fuels
IPO
27/06/2006
Employees 220

Ticker symbols

Exchange Symbol
NASDAQ
AMTX
Frankfurt
DW51.F
DĂĽsseldorf
DW51.DU
MĂĽnchen
DW51.MU
🍪

Parqet  uses cookies. Learn more